Literature DB >> 2285287

Effects of enoxacin on renal and metabolic clearance of theophylline in rats.

M Nadai1, T Hasegawa, T Kuzuya, I Muraoka, K Takagi, H Yoshizumi.   

Abstract

The effects of enoxacin and its metabolite 4-oxoenoxacin on the disposition of theophylline were investigated in rats. Systemic clearance of theophylline was significantly decreased by approximately 40, 46, and 50% after oral coadministration of 25, 100, and 200 mg of enoxacin per kg, respectively. No significant changes in the volume of distribution of theophylline were observed. 4-Oxoenoxacin had no direct effect on theophylline disposition. Significant changes in urinary excretion of theophylline and its metabolites were observed. (i) Urinary excretion of unchanged theophylline was significantly increased in proportion to increases in enoxacin dosage. (ii) Decreases in renal clearance of theophylline and metabolic clearance of 1-methyluric acid and 1,3-dimethyluric acid were observed. (iii) The percent decreases in the metabolic clearance of 1-methyluric acid were dependent on enoxacin dosage. It is likely that enoxacin inhibits the elimination process, which depends on cytochrome P-450-mediated isozymes for N demethylation and oxidation, and that the capacity of the inhibitory effect of enoxacin is greater in the N-demethylation pathway than it is in oxidation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2285287      PMCID: PMC171915          DOI: 10.1128/AAC.34.9.1739

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  Paraxanthine metabolism in humans: determination of metabolic partial clearances and effects of allopurinol and cimetidine.

Authors:  A Lelo; G Kjellen; D J Birkett; J O Miners
Journal:  J Pharmacol Exp Ther       Date:  1989-01       Impact factor: 4.030

2.  Inhibitory effect of enoxacin, ofloxacin and norfloxacin on renal excretion of theophylline in humans.

Authors:  M Sano; K Kawakatsu; I Yamamoto; M Takeyama; H Yamashina; M Goto
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

3.  Effects of phenobarbital and 3-methylcholanthrene pretreatment on the plasma half-life and urinary excretion profile of theophylline and its metabolites in rats.

Authors:  J F Williams; S Lowitt; A Szentivanyi
Journal:  Biochem Pharmacol       Date:  1979-10-01       Impact factor: 5.858

4.  Effect of enoxacin and 4-oxo-enoxacin on antipyrine disposition in the rat.

Authors:  D J Edwards; N M Waite; C K Svensson
Journal:  Drug Metab Dispos       Date:  1988 Jul-Aug       Impact factor: 3.922

5.  Antipyrine metabolism in the rat by three hepatic monooxygenases.

Authors:  T Inaba; M Lucassen; W Kalow
Journal:  Life Sci       Date:  1980-06-09       Impact factor: 5.037

Review 6.  Inhibition of drug metabolism by quinolone antibiotics.

Authors:  D J Edwards; S K Bowles; C K Svensson; M J Rybak
Journal:  Clin Pharmacokinet       Date:  1988-09       Impact factor: 6.447

7.  Theophylline metabolism by the rat liver microsomal system.

Authors:  S M Lohmann; R P Miech
Journal:  J Pharmacol Exp Ther       Date:  1976-01       Impact factor: 4.030

8.  Comparative studies on interaction between theophylline and quinolones.

Authors:  K Takagi; T Hasegawa; Y Ogura; R Suzuki; K Yamaki; T Watanabe; S Kitazawa; T Satake
Journal:  J Asthma       Date:  1988       Impact factor: 2.515

9.  Cimetidine: a specific inhibitor of hepatic aryl hydrocarbon hydroxylase (AHH) in the rat.

Authors:  R Drew; J Rowell; J J Grygiel
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1981-07

10.  Evaluation of the effect of norfloxacin on the pharmacokinetics of theophylline.

Authors:  G Ho; M G Tierney; R E Dales
Journal:  Clin Pharmacol Ther       Date:  1988-07       Impact factor: 6.875

View more
  4 in total

1.  Influence of a newly developed quinolone, T-3761, on pharmacokinetics of theophylline in rats.

Authors:  T Hasegawa; M Nadai; S Haghgoo; K Yamaki; K Takagi; T Nabeshima
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

2.  Kinetic interaction between theophylline and a newly developed anti-allergic drug, pemirolast potassium.

Authors:  T Hasegawa; K Takagi; M Nadai; Y Ogura; T Nabeshima
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

3.  Effect of a new quinolone, sparfloxacin, on the pharmacokinetics of theophylline in asthmatic patients.

Authors:  K Takagi; K Yamaki; M Nadai; T Kuzuya; T Hasegawa
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

4.  Applicability of free drug hypothesis to drugs with good membrane permeability that are not efflux transporter substrates: A microdialysis study in rats.

Authors:  Chun Chen; Hongyu Zhou; Chi Guan; Huanhuan Zhang; Yingying Li; Xue Jiang; Zheng Dong; Yuanyuan Tao; Juan Du; Shuyao Wang; Teng Zhang; Na Du; Junyang Guo; Yaqiong Wu; Zehai Song; Haofei Luan; Yu Wang; Hongwen Du; Shaofeng Zhang; Chen Li; Hang Chang; Tao Wang
Journal:  Pharmacol Res Perspect       Date:  2020-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.